These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


186 related items for PubMed ID: 22243526

  • 1. Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens.
    Santagati M, Scillato M, Patanè F, Aiello C, Stefani S.
    FEMS Immunol Med Microbiol; 2012 Jun; 65(1):23-31. PubMed ID: 22243526
    [Abstract] [Full Text] [Related]

  • 2. Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics.
    Wescombe PA, Heng NC, Burton JP, Chilcott CN, Tagg JR.
    Future Microbiol; 2009 Sep; 4(7):819-35. PubMed ID: 19722837
    [Abstract] [Full Text] [Related]

  • 3. Probiotics Streptococcus salivarius 24SMB and Streptococcus oralis 89a interfere with biofilm formation of pathogens of the upper respiratory tract.
    Bidossi A, De Grandi R, Toscano M, Bottagisio M, De Vecchi E, Gelardi M, Drago L.
    BMC Infect Dis; 2018 Dec 13; 18(1):653. PubMed ID: 30545317
    [Abstract] [Full Text] [Related]

  • 4. Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media?
    Walls T, Power D, Tagg J.
    J Med Microbiol; 2003 Sep 13; 52(Pt 9):829-833. PubMed ID: 12909662
    [Abstract] [Full Text] [Related]

  • 5. A new alkaline pH-adjusted medium enhances detection of beta-hemolytic streptococci by minimizing bacterial interference due to Streptococcus salivarius.
    Dierksen KP, Ragland NL, Tagg JR.
    J Clin Microbiol; 2000 Feb 13; 38(2):643-50. PubMed ID: 10655361
    [Abstract] [Full Text] [Related]

  • 6. Persistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics.
    Burton JP, Wescombe PA, Macklaim JM, Chai MH, Macdonald K, Hale JD, Tagg J, Reid G, Gloor GB, Cadieux PA.
    PLoS One; 2013 Feb 13; 8(6):e65991. PubMed ID: 23785463
    [Abstract] [Full Text] [Related]

  • 7. Isolation and Bacteriocin-Related Typing of Streptococcus dentisani.
    Conrads G, Westenberger J, Lürkens M, Abdelbary MMH.
    Front Cell Infect Microbiol; 2019 Feb 13; 9():110. PubMed ID: 31041198
    [Abstract] [Full Text] [Related]

  • 8. Variable characteristics of bacteriocin-producing Streptococcus salivarius strains isolated from Malaysian subjects.
    Barbour A, Philip K.
    PLoS One; 2014 Feb 13; 9(6):e100541. PubMed ID: 24941127
    [Abstract] [Full Text] [Related]

  • 9. In-vitro bacteriocin-mediated antagonism by oral streptococci against human carrier strains of staphylococci.
    Tzannetis SE, Bigis A, Konidaris N, Ioannidis H, Genimatas V, Papavassiliou J.
    J Appl Bacteriol; 1991 Apr 13; 70(4):294-301. PubMed ID: 2055791
    [Abstract] [Full Text] [Related]

  • 10. Oral bacteria as potential probiotics for the pharyngeal mucosa.
    Guglielmetti S, Taverniti V, Minuzzo M, Arioli S, Stuknyte M, Karp M, Mora D.
    Appl Environ Microbiol; 2010 Jun 13; 76(12):3948-58. PubMed ID: 20418429
    [Abstract] [Full Text] [Related]

  • 11. Bacteriocin production and sensitivity among coaggregating and noncoaggregating oral streptococci.
    Tompkins GR, Peavey MA, Birchmeier KR, Tagg JR.
    Oral Microbiol Immunol; 1997 Apr 13; 12(2):98-105. PubMed ID: 9227133
    [Abstract] [Full Text] [Related]

  • 12. Streptococcus salivarius 24SMB administered by nasal spray for the prevention of acute otitis media in otitis-prone children.
    Marchisio P, Santagati M, Scillato M, Baggi E, Fattizzo M, Rosazza C, Stefani S, Esposito S, Principi N.
    Eur J Clin Microbiol Infect Dis; 2015 Dec 13; 34(12):2377-83. PubMed ID: 26385346
    [Abstract] [Full Text] [Related]

  • 13. Lactobacillus salivarius: bacteriocin and probiotic activity.
    Messaoudi S, Manai M, Kergourlay G, Prévost H, Connil N, Chobert JM, Dousset X.
    Food Microbiol; 2013 Dec 13; 36(2):296-304. PubMed ID: 24010610
    [Abstract] [Full Text] [Related]

  • 14. Genome sequence of the bacteriocin-producing oral probiotic Streptococcus salivarius strain M18.
    Heng NC, Haji-Ishak NS, Kalyan A, Wong AY, Lovric M, Bridson JM, Artamonova J, Stanton JA, Wescombe PA, Burton JP, Cullinan MP, Tagg JR.
    J Bacteriol; 2011 Nov 13; 193(22):6402-3. PubMed ID: 22038965
    [Abstract] [Full Text] [Related]

  • 15. In vitro functional and immunomodulatory properties of the Lactobacillus helveticus MIMLh5-Streptococcus salivarius ST3 association that are relevant to the development of a pharyngeal probiotic product.
    Taverniti V, Minuzzo M, Arioli S, Junttila I, Hämäläinen S, Turpeinen H, Mora D, Karp M, Pesu M, Guglielmetti S.
    Appl Environ Microbiol; 2012 Jun 13; 78(12):4209-16. PubMed ID: 22504812
    [Abstract] [Full Text] [Related]

  • 16. Genome sequence of the lantibiotic bacteriocin producer Streptococcus salivarius strain K12.
    Barretto C, Alvarez-Martin P, Foata F, Renault P, Berger B.
    J Bacteriol; 2012 Nov 13; 194(21):5959-60. PubMed ID: 23045482
    [Abstract] [Full Text] [Related]

  • 17. Interactions between oral bacteria: inhibition of Streptococcus mutans bacteriocin production by Streptococcus gordonii.
    Wang BY, Kuramitsu HK.
    Appl Environ Microbiol; 2005 Jan 13; 71(1):354-62. PubMed ID: 15640209
    [Abstract] [Full Text] [Related]

  • 18. Purification and genetic characterization of gassericin E, a novel co-culture inducible bacteriocin from Lactobacillus gasseri EV1461 isolated from the vagina of a healthy woman.
    Maldonado-Barragán A, Caballero-Guerrero B, Martín V, Ruiz-Barba JL, Rodríguez JM.
    BMC Microbiol; 2016 Mar 12; 16():37. PubMed ID: 26969428
    [Abstract] [Full Text] [Related]

  • 19. Characterization of a Multipeptide Lantibiotic Locus in Streptococcus pneumoniae.
    Maricic N, Anderson ES, Opipari AE, Yu EA, Dawid S.
    mBio; 2016 Jan 26; 7(1):e01656-15. PubMed ID: 26814178
    [Abstract] [Full Text] [Related]

  • 20. Purification and genetic characterisation of the novel bacteriocin LS2 produced by the human oral strain Lactobacillus salivarius BGHO1.
    Busarcevic M, Dalgalarrondo M.
    Int J Antimicrob Agents; 2012 Aug 26; 40(2):127-34. PubMed ID: 22739096
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.